Abstract
Localized proton magnetic resonance spectroscopy (MRS) with short echo times provides unique information of human cerebral metabolism. Studies on patients with portal-systemic encephalopathy (PSE) have been performed to clarify the pathogenesis of this disease and to find a method which allows an objective diagnosis. Spectra of patients with PSE show typical abnormalities. Regional variations of these spectral changes are observed. The metabolic changes correlate with the grade of encephalopathy but the dependence on the Child-Pugh score is controversial. No causal dependence between MRS findings and abnormalities in magnetic resonance imaging is evident. Differences in magnetic resonance spectra in patients compared to controls vanish after liver transplantation, but increase after TIPS. The results of proton magnetic resonance spectroscopy are important for an understanding of the pathogenesis of PSE, but do not aid in the diagnosis of subclinical hepatic encephalopathy.
Similar content being viewed by others
REFERENCES
Becker, G., Rohr, G., Gückel, F., Holm, E., Loose, R. and Georgi, M. (1994). Follow up of hepatic encephalopathy by localized proton MR spectroscopy of the human brain [abstract]. Soc Magn. Reson. 2:570.
Bottomley, P.A. (1987). Spatial localization in NMR-spectroscopy in vivo. Proc. NY Acad. Sci. 508:333–348.
Bottomley, P.A. (1992). Proton MR spectroscopy for diagnosing hepatic encephalopathy. Radiol. 182:6–7.
Bruhn, H., Frahm, J., Michaelis, T., Merboldt, K.D., Hänicke, W., Gyngell, M.L. et al. (1991a). Metabolic disturbances of the brain in patients with liver cirrhosis detected by proton magnetic resonance spectroscopy [abstract]. Hepatol. 14:121.
Bruhn, H., Merboldt, K.D., Michaelis, T., Gyngell, M.L., Hänicke, W., Frahm, J. et al. (1991b). Proton MRS of metabolic disturbances in the brain of patients with liver cirrhosis and subclinical hepatic encephalopathy [abstract]. Soc. Magn. Reson. Med. 10:400.
Brunberg, J.A. Kanal, E., Hirsch, W. and Van Thiel, D.H. (1993). Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T. AJNR 12:909–914.
Butterworth, R.F., Giguere, J.F., Michaud J. and Layrargues, G.P. (1987). Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem. Pathol. 6:1–12.
Chamuleau, R., Bosman, D.K., Bovée, W., Luyten, P.R. and den Hollander, J.A. (1991). What the clinician can learn from MR glutamine/glutamate assays. NMR in Biomedicine 4:103–108.
Chamuleau, R., Bosman, D.K., Bovée, W., Luyten, P.R., den Hollander, J.A. (1994). In vivo brain magnetic resonance imaging (MRI) and magnetic resonance spectroscopy in hepatic encephalopathy. In (V. Felipo, S. Grisolia, eds.) Hepatic Encephalopathy, Hyperammonia, and Ammonia Toxicity, Plenum Press, New York, pp. 23–31.
Danielsen, E.R., Ernst, T., Geissler, A., Villamil, F., Michaelis, T. and Ross, B.D. (1995). Is hepatic encephalopathy a disturbance of cerebral osmolytes? [abstract]. Soc. Magn. Resan. 3:1839.
Frahm, J., Merboldt, K.D. and Hänicke, W. (1987). Localized proton spectroscopy using stimulated echoes. J. Magn. Reson. 72:502.
Frahm, J., Bruhn, H., Michaelis, T., Merboldt, K.D., Hänicke, W. and Gyngell, M.L. (1991) Localized proton MR spectroscopy. Radiol. 31:558–566.
Geissler, A., Farrow, N.A., Villamil, F., Makowka, L., Ernst, T., Kreis, R. and Ross, B.D. (1992). Is hepatic encephalopathy reversed by liver transplantation? [abstract]. Soc. Magn. Reson. Med. 11:6–47.
Geissler, A., Lock, G., Fründ, R., Held, P., Hollerbach, S., Andus, T. et al. (1997). Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatol. 25:48–54.
Granot, J. (1986). Selected volume excitation using stimulated echoes (VEST) — Applications to spatially localized spectroscopy and imaging. J. Magn. Reson. 70:488–492.
Hanner, J.S., Li, K.C.P. and Davis, G.L. (1988). Acquired hepatocerebral degeneration: MR similarity with Wilson disease. J. Comp. Ass. Tomograph. 12:1076–1077.
Haseler, L.J., Agarwal, V., Sibbitt, W.L., Brooks, W.M., Hart, B.L. and Matwiyoff, N.A. (1992). Chronic hepatic encephalopathy: reversal of 1H MR spectra following liver transplantation [abstract]. Soc. Magn. Reson. Med. 11:1014.
Häussinger, D., Laubenberger, J., Vom Dahl, S., Ernst, T., Bayer, S., Langer, M. et al. (1994). Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterol. 107:1475–1480.
Huda, A., Thomas, A., Bugbee, M., Ke, Y., Oshiro, T., Strouse, T., Curran, J. and Guze, B. (1995). Regional variations of metabolites in hepatic encephalopathy [abstract]. Soc. Magn. Reson. 3:1838
Huda, A., Thomas, A., Buze, B., Curran, J., Fairbanks, L., Bugbee, M. and Fawzy, F.I. (1997). MR spectroscopy and neuropsychological characterization of subclinical hepatic encephalopathy: a clinical correlation study [abstract]. Int. Soc. Magn. Reson. Med. 5:533
Inoue, E., Hori, S., Narumi, Y., Fujita, M., Kuriyama, K., Kadota, T. and Kuroda, C. (1991). Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiol. 179:551–555.
Kimmich, R. and Hoepfel, D. (1987). Volume selective multipulse spin-echo spectroscopy. J. Magn. Reson. 72:379–384.
Köstler, H., Dietrich, B., Ahl, B., Fischer-Wasel, D., Manns, M.P., Becker, H. and Weissenborn, K. (1997). Variations in 1H MRS in patients with portosystemic encephalopathy: dependence on location and clinical status [abstract]. Int. Soc. Magn. Reson. Med. 5:1240.
Kreis, R., Farrow, N.A. and Ross, B.D. (1990). Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 336:635–636.
Kreis, R., Farrow N. and Ross, B.D. (1991). Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy analysis of changes in cerebral glutamine, choline and inositols. NMR in Biomedicine 4:109–116.
Kreis, R., Ross, B.D., Farrow, N.A. and Ackerman, Z. (1992). Metabolic disorder of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiol. 182:19–27.
Kulisevsky, J., Pujol, J., Balanzo, J., Junque, C., Deus, J., Capdevila, A. and Villanueva, C. (1992). Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatol. 16:1382–1388.
Kulisevsky, J., Pujol, J., Junque, C., Deus, J., Balanzo, J. and Capdevila, A. (1993). MRI pallidial hyperintensity and brain atrophy in cirrhotic patients: Two different MRI patterns of clinical deterioration? Neurol. 43:2570–2573.
Laubenberger, J., Häussinger, D., Bayer, S., Gufler, H., Hennig, J. and Langer, M. (1997). Proton magnetic resonance spectroscopy on the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterol. 112:1610–1616.
Laubenberger, J., Bayer, S., Thiel, J., Hennig, J. and Langer, M. (1998). Clinical application of proton magnetic resonance spectroscopy of the brain. Fortschr. Röntgenstr. 168:539–549.
Lee, J.H., Choi, C.G., Lee, Y.S., Suh, D.C. and Lim, T.H. (1995). Localized 1H MR spectroscopy of the basal ganglia in liver cirrhosis and hepatic encephalopathy [abstract]. Soc. Magn. Reson. 3:1837.
Lockwood, A.H., Yap, E.W.H., Rhoades, H.M. and Wong, W.H. (1991). Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J. Cereb. Blood Flow Metab. 11:331–336.
Lockwood, A.H., Murphy, B.W., Donnelly, K.Z., Mahl, T.C. and Perini, S. (1993). Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatol. 18:1061–1068.
Marcus, C.D., Sargentoni, J., Bryant, D.J. and Taylor-Robinson, S.D. (1994). 1H MRS in patients with chronic hepatic encephalopathy — regional variations [abstract]. Soc. Magn. Reson. 2:571.
Morgan, M. (1996). Noninvasive neuroinvestigation in liver disease. Semin. Liver Dis. 16:293–314.
Nägele, T., Seeger, U., Klose, U., Seitz, D., Viebahn, R., Grodd, W., Voigt, K. (1998). MR imaging and short echo-time localized 1H spectroscopy of the brain in hepatic encephalopathy: follow up after liver transplantation [abstract]. Int. Soc. Magn. Reson. Med. 4:305.
Nägele, T., Seeger, U., Klose, U., Seitz, D., Viebahn, R. and Grodd, W. (1997). 1H Spektroskopie des Gehirns zur Verlaufsbeurteilung der hepatischen Enzephalopathie vor und nach Lebertransplantation unter besonderer Ber cksichtigung des Langzeitverlaufs [abstract]. Fortschr. Röntgenstr. 166:S93.
Nägele, T., Seeger, U., Klose, U., Britsch, S., Wilms, P., Seitz, D. et al. (1996). Localized 1H spectroscopy of the brain with ultra-short echo times in hepatic encephalopathy including follow up after liver transplantation [abstract]. Int. Soc. Magn. Reson. Med. 6:1747.
Norenberg, M.D. and Bender, A.S. (1994). Astrocyte swelling in liver failure: role of glutamine and benzodiazepines. Acta Neurochir. [Suppl] 60:24–27.
Pujol, A., Graus, F., Peri, J., Mercader, J.M. and Rimola, A. (1991). Hyperintensity in the globus pallidus on T1-weighted and inversion recovery MRI: a possible marker of advanced liver disease. Neurol. 41:1526–1527.
Pujol, A., Pujol, J., Graus, F., Rimola, A., Peri, J., Mercader, J.M. et al. (1993). Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurol. 43:65–69.
Pujol, J., Kulisevski, J., Moreno, A., Deus, J., Alonso, J., Balanzó, J. et al. (1996). Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurol. 47:1526–1530.
Raabe W. (1987). Synaptic transmission in ammonia intoxication. Neurochem. Pathol. 6:145–166.
Ross, B.D. (1991). Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR in Biomedicine 4:59–63.
Ross, B.D., Shonk, T., Moats, R.A., Jacobson S., Draguesku, J., Ernst, T. et al. (1993a). 1H MRS for the diagnosis of sub-clinical hepatic encephalopathy [abstract]. Soc. Magn. Reson. Med. 12:131.
Ross, B.D., Jacobson S., Villamil, F.G., Moats, R.A., Shonk, T. and Draguesku, J. (1993b). Cerebral myo-inositol depletion defines subclinical hepatic encephalopathy [abstract]. Hepatol. 118:105 A.
Ross, B.D., Jacobson S., Villamil, F., Korula, J., Kreis, R., Ernst, T. et al. (1994). Subclinical hepatic encephalopathy: Proton MR spectroscopic abnormalities. Radiol. 193:457–463.
Ross, B.D. and Michaelis, T. (1994). Clinical applications of magnetic resonance spectroscopy. Magn. Res. Quarterly 10:191–247.
Ross, B.D., Katz, M., Kordula, J., Shonk, T., Mandigo, J.C. and Reynolds, T. (1995). Predicting clinical hepatic encephalopathy after tips. [abstract]. Soc. Magn. Reson. 3:1840.
Seery, J.P. and Taylor-Robinson, S.D. (1996). The application of magnetic resonance spectroscopy to the study of hepatic encephalopathy. J. Hepatol. 25:988–998.
Schenker, S. and Butterworth, R. (1997). NMR spectroscopy in portal-systemic encephalopathy: are we there yet? Gastroenterol. 112:1758–1761.
Seo, D.W., Lee, J.H., Kim, S.T., Chung, Y.H., Lee, Y.S. and Lim, T.H. (1997). Proton magnetic resonance spectroscopy findings in patients with liver cirrhosis: decreased myo-inositol/creatine ratio does not reflect the severity of hepatic encephalopathy [abstract]. Int. Soc. Magn. Reson. Med. 5:534
Seo, D.W., Lee, J.H., Lee, Y.S., Kim, S.T., Suh, D.J., Min, Y.I. and Lim, T.H. (1998). Proton magnetic resonance spectroscopy findings in cirrhotic patients without overt hepatic encephalopathy: does the myoinositol/creatine ratio reflect hepatic functional reserve? [abstract]. Int. Soc. Magn. Reson. Med. 6:1719.
Taylor-Robinson, S.D., Sargentoni, J., Marcus, C.D., Morgan, M.Y. and Bryant, D.J. (1994). Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab. Brain Dis. 9:347–359.
Taylor-Robinson, S.D., Oatridge, A., Hajnal J.V., Burroughs, A.K., McIntyre, N. and deSouza, N.M. (1995). MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetization transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab. Brain Dis. 10:175–188.
Weissenborn, K., Burchert, W., Bokemeyer, M., Ehrenheim, C., Kolbe, H., Manns, M.P. and Dengler, R. (1997). Regional differences of cerebral glucose metabolism in patients with liver cirrhosis depending on the grade of portosystemic encephalopathy (PSE). In (C. Record and H. Al-Mardini, eds.) Advances in Hepatic Encephalopathy and Metabolism in Liver Disease, Medical Faculty University of Newcastle upon Tyne, Newcastle upon Tyne, pp. 359–363.
Weissenborn, K. and Kolbe, H. (1998). The basal ganglia and portosystemic encephalopathy. Metab. Brain Dis.(this volume).
Zeneroli, M.L. Cioni, G., Crisi, G., Vezzelli, C. and Ventura, E. (1991). Globus pallidus alteration and brain atrophy in liver cirrhosis patients with encephalopathy: A MRI imaging study. Magn. Res. Imaging 9:295–302.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Köstler, H. Proton Magnetic Resonance Spectroscopy in Portal-Systemic Encephalopathy. Metab Brain Dis 13, 291–301 (1998). https://doi.org/10.1023/A:1020632708154
Issue Date:
DOI: https://doi.org/10.1023/A:1020632708154